Pregnancy in Chronic Kidney Disease

  • Weichun HeEmail author


Although the pregnancy rate of women with chronic kidney disease (CKD) and the overall survival rate of their fetuses have improved, pregnancy in women with CKD still have a high risk of adverse maternal and fetal outcomes. To achieve better outcomes for this particular population, managing pregnancy in women with CKD has become a considerable challenge shared by both nephrologists and obstetricians. Strengthened management, including prepregnancy preparation, pregnancy management, peripartum management, and postpartum care, could prevent or mitigate maternal renal damage and adverse maternal and fetal outcomes. Women with CKD require risk assessment of pregnancy before conceiving, close follow-up by both nephrologists and obstetricians to monitor disease activity and detect obstetric complications during pregnancy, evaluation of indications for termination of pregnancy and selection of delivery mode, and assessment of disease activity and emotional support to prevent depression after delivery.


  1. 1.
    Hladunewich MA, et al. Managing glomerular disease in pregnancy. Nephrol Dial Transplant. 2017;32(suppl_1):i48–56.CrossRefGoogle Scholar
  2. 2.
    Park S, et al. Midterm eGFR and adverse pregnancy outcomes: the clinical significance of gestational hyperfiltration. Clin J Am Soc Nephrol. 2017;12(7):1048–56.CrossRefGoogle Scholar
  3. 3.
    National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266.Google Scholar
  4. 4.
    Levey AS, et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2005;67(6):2089–100.CrossRefGoogle Scholar
  5. 5.
    Levey AS, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130(6):461–70.CrossRefGoogle Scholar
  6. 6.
    Levey AS, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.CrossRefGoogle Scholar
  7. 7.
    Hladunewich MA. Chronic kidney disease and pregnancy. Semin Nephrol. 2017;37(4):337–46.CrossRefGoogle Scholar
  8. 8.
    Piccoli GB, et al. Risk of adverse pregnancy outcomes in women with CKD. J Am Soc Nephrol. 2015;26(8):2011–22.CrossRefGoogle Scholar
  9. 9.
    Piccoli GB, et al. Hypertension in CKD pregnancy: a question of cause and effect (cause or effect? This is the question). Curr Hypertens Rep. 2016;18(5):35.CrossRefGoogle Scholar
  10. 10.
    Bramham K, et al. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ. 2014;348:g2301.CrossRefGoogle Scholar
  11. 11.
    Barbour SJ, et al. Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis. Kidney Int. 2012;81(2):190–5.CrossRefGoogle Scholar
  12. 12.
    Hladunewich MA, Melamad N, Bramham K. Pregnancy across the spectrum of chronic kidney disease. Kidney Int. 2016;89(5):995–1007.CrossRefGoogle Scholar
  13. 13.
    Blom K, et al. Pregnancy and glomerular disease: a systematic review of the literature with management guidelines. Clin J Am Soc Nephrol. 2017;12(11):1862–72.CrossRefGoogle Scholar
  14. 14.
    Buyon JP, et al. Kidney outcomes and risk factors for nephritis (flare/De novo) in a multiethnic cohort of pregnant patients with lupus. Clin J Am Soc Nephrol. 2017;12(6):940–6.CrossRefGoogle Scholar
  15. 15.
    Alkhunaizi A, Melamed N, Hladunewich MA. Pregnancy in advanced chronic kidney disease and end-stage renal disease. Curr Opin Nephrol Hypertens. 2015;24(3):252–9.CrossRefGoogle Scholar
  16. 16.
    Wyld ML, et al. Pregnancy outcomes for kidney transplant recipients. Am J Transplant. 2013;13(12):3173–82.CrossRefGoogle Scholar
  17. 17.
    Deshpande NA, et al. Pregnancy outcomes in kidney transplant recipients: a systematic review and meta-analysis. Am J Transplant. 2011;11(11):2388–404.CrossRefGoogle Scholar
  18. 18.
    Transplantation EEGoR. European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. IV.10. Pregnancy in renal transplant recipients. Nephrol Dial Transplant. 2002;17(Suppl 4):50–5.Google Scholar
  19. 19.
    McKay DB, et al. Reproduction and transplantation: report on the AST consensus conference on reproductive issues and transplantation. Am J Transplant. 2005;5(7):1592–9.CrossRefGoogle Scholar
  20. 20.
    Lidegaard O, et al. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med. 2012;366(24):2257–66.CrossRefGoogle Scholar
  21. 21.
    Bailie GR, et al. Sexual dysfunction in dialysis patients treated with antihypertensive or antidepressive medications: results from the DOPPS. Nephrol Dial Transplant. 2007;22(4):1163–70.CrossRefGoogle Scholar
  22. 22.
    Mok CC, et al. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide. Am J Med. 2006;119(4):355 e25–33.CrossRefGoogle Scholar
  23. 23.
    Diav-Citrin O, et al. Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers. Reprod Toxicol. 2011;31(4):540–5.CrossRefGoogle Scholar
  24. 24.
    Murphy KE, et al. Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial. Lancet. 2008;372(9656):2143–51.CrossRefGoogle Scholar
  25. 25.
    Clowse ME, et al. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum. 2006;54(11):3640–7.CrossRefGoogle Scholar
  26. 26.
    Coscia LA, et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl. 2010:65–85.Google Scholar
  27. 27.
    Kim H, et al. The optimal therapy of calcineurin inhibitors for pregnancy in kidney transplantation. Clin Transpl. 2015;29(2):142–8.CrossRefGoogle Scholar
  28. 28.
    Zheng S, et al. Pharmacokinetics of tacrolimus during pregnancy. Ther Drug Monit. 2012;34(6):660–70.CrossRefGoogle Scholar
  29. 29.
    Ostensen M, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther. 2006;8(3):209.CrossRefGoogle Scholar
  30. 30.
    Chakravarty EF, et al. Pregnancy outcomes after maternal exposure to rituximab. Blood. 2011;117(5):1499–506.CrossRefGoogle Scholar
  31. 31.
    American College of, O., Gynecologists, and P. Task Force on Hypertension in, Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013;122(5):1122–31.CrossRefGoogle Scholar
  32. 32.
    Magee LA, et al. Do labetalol and methyldopa have different effects on pregnancy outcome analysis of data from the control of hypertension in pregnancy study (CHIPS) trial. BJOG. 2016;123(7):1143–51.CrossRefGoogle Scholar
  33. 33.
    Xie RH, et al. Association between labetalol use for hypertension in pregnancy and adverse infant outcomes. Eur J Obstet Gynecol Reprod Biol. 2014;175:124–8.CrossRefGoogle Scholar
  34. 34.
    Cooper WO, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006;354(23):2443–51.CrossRefGoogle Scholar
  35. 35.
    Bates SM, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e691S–736S.CrossRefGoogle Scholar
  36. 36.
    American Diabetes Association. 12. Management of diabetes in pregnancy. Diabetes Care. 2016;39(Suppl 1):S94–8.Google Scholar
  37. 37.
    Stover J. Nutritional management of pregnancy in chronic kidney disease. Adv Chronic Kidney Dis. 2007;14(2):212–4.CrossRefGoogle Scholar
  38. 38.
    Piccoli GB, et al. Association of low-protein supplemented diets with fetal growth in pregnant women with CKD. Clin J Am Soc Nephrol. 2014;9(5):864–73.CrossRefGoogle Scholar
  39. 39.
    Piccoli GB, et al. Pregnancy and chronic kidney disease: a challenge in all CKD stages. Clin J Am Soc Nephrol. 2010;5(5):844–55.CrossRefGoogle Scholar
  40. 40.
    National Center for. Clinical medical research on renal disease, guidelines for pregnancy management in patients with chronic kidney disease. Natl J Med China. 2017;97(12):3604–11.Google Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  1. 1.Centre for Kidney DiseaseSecond Affiliated Hospital, Nanjing Medical UniversityNanjingChina

Personalised recommendations